Document Fragment View

Matching Fragments

21. The plaintiff submits that the suit patent IN'902 relates to synergistic nutritional compositions comprising therapeutically active nutrients alongwith pharmaceutically acceptable carriers for regulating myelination and axonal growth or regulating myelin and axon biology or regulating neural circuit function. The suit patent IN'902 provides potent nutritional composition comprising synergistic exogenous blend of agmatine (AGM) (decarboxylated Larginine) and inosine monophosphate (IMP) and salts thereof present in suitable weight ratio, along with pharmaceutically acceptable excipients. The said synergistic nutritional composition is useful for treating diseases or disorders related to traumatic injury in the central nervous system such as brain or spinal cord injury, or optic nerve lesions. Independent Claim of IN'902 as also the details thereof are enumerated as under:-

"1. A stable, synergistic composition for promoting axonal regeneration comprising therapeutically effective exogenous combination of crystalline form of inosine monophosphate and agmatine and salts thereof, wherein the inosine monophosphate salt and the agmatine salt are present in a weight ratio of 1:0.05 to 1 :2 along with pharmaceutically acceptable excipients, wherein the inosine monophosphate disodium salt hydrate is present in a range of 40% to 90% by weight of the total composition, and wherein the agmatine sulphate is present in a range of 10% to 55% by weight of the total composition. "
"1. A synergistic nutritional composition(s) comprising a therapeutic blend of palmitoylethanolamide (PEA) and standardized red spinach extract enriched with nitrate content, wherein the PEA and the standardized red spinach extract 27 enriched with nitrate content are present in a ratio of 1:0.1 to 1:5, along with pharmaceutically acceptable excipients."

28. The suit patent IN'765 relates to synergistic bioactive composition comprising naturally derived moieties for reliving neuropathic pain. Particularly, the suit patent IN'765 relates to potent bioactive compositions comprising of synergistic combination of fatty acid amide and pyrimidine nucleotides along with phannaceutically acceptable excipients; wherein the fatty acid amide is palmitoylethanolamide (PEA), the pyrimidine nucleotides are cytidine-5'-monophosphate (CMP) and uridine 5'- monophosphate (UMP). Further the said synergistic composition is useful for treatment of polyneuropathies, neuritides, myopathies, complex neuropathies, chronic inflammation, demyelinating polyneuropathy diabetic polyneuropathies, multiple sclerosis, spinal syndromes, and neuralgia. Independent Claim of Indian Patent IN'765 as also details thereof are enumerated below:-